Cervical Cytology Findings and Microorganisms Among Sudanese Women at Soba Teaching Hospital: Implications for Screening and Awareness

Document Type : Original Article

Authors

1 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, University of Medical Sciences and Technology, Khartoum, Sudan.

2 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, Wad Medani University of Sciences and Technology.

3 Napata College, SQ.10 building 151, Alreyadh, Khartoum, Sudan

4 Cervical Cancer Prevention & Research (CCPR) Unit, Department of Obstetrics & Gynaecology, Soba University Hospital, Khartoum Postal Code 13314, Sudan.

5 Department of Histopathology and Cytology, Faculty of Medical Laboratory Sciences, University of Medical Sciences and Technology, Khartoum, Sudan

6 Department of Pathology, Faculty of Medicine, The National Ribat University, Khartoum, Sudan

7 Department of Obstetrics & Gynaecology, Faculty of Medicine, University of Khartoum, Khartoum Postal Code 11115, Sudan

8 Department of Pathology, Faculty of Medicine and Health Sciences, Omdurman Islamic University, Khartoum, Sudan

9 Department of Preventive Medicine and Public health, College of Veterinary Medicine, Sudan University of Science and Technology

Abstract

Background: Cervical cancer is the second most common cancer in Sudanese women after breast cancer. Pap smear screening is an effective diagnostic procedure for early detection. This study aimed to identify cytomorphological patterns in Pap smears from Sudanese females attending the Cervical Cancer Prevention and Research Unit (CCPRU) at Soba Teaching Hospital (STH) in Khartoum, Sudan. Methods: This study was a descriptive, cross-sectional, laboratory-based study conducted at CCPRU, STH, Khartoum, Sudan, from December 2020 to June 2021. The study included 118 Sudanese females, age and reproductive status varied. Pap smears were processed using the Pap stain method (Bancroft, 1990). Demographic and clinical data were collected from patient records. Cytological findings were reported based on the Bethesda System 2013. For statistical analysis,  SPSS version 23.0 was used. Results: The majority (71.2%) of participants were aged 15-45 years. Cytological diagnoses included NILM (69.5%), HSIL (13.5%), LSIL (12.7%), ASCUS (2.5%), SCC (0.9%), and adenocarcinoma (0.9%). Microorganisms included bacterial vaginosis (21 cases), Actinomyces (3 cases), cellular changes consistent with HPV (14 cases), candida (7 cases), cellular changes consistent with HSV (6 cases) and Trichomonas vaginalis (1 case). The association between cytological findings with the age group and the clinical symptoms proved to be statistically insignificant, while it is significant when related to the cytological characteristics according to the Bethesda system. Conclusion: Cervical cytology is vital for detecting precancerous and cancerous lesions in Sudanese women. The majority of participants were aged 15-45 years, and HSIL was the most common lesion. Establishing regular screening programs and raising awareness about cervical cancer are recommended

Keywords

Main Subjects


 
Ali, K. E.; Mohammed I. A.; Difabachew, M. N.; Demeke, D. S.; Haile, T.; Ten Hove, R. J.; Kumssa, T. H., Woldu, Z. L.;, Haile, E. L.; Tullu, K. D. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia. BMC cancer. 2019 Dec;19(1):1-9.
Almobarak AO, Elbadawi AA, Elmadhoun WM, Elhoweris MH, Ahmed MH. Knowledge, Attitudes and Practices of Sudanese Women Regarding the Pap Smear Test and Cervical Cancer. Asian Pacific Journal of Cancer Prevention [Internet]. 2016 Mar 7;17(2):625–30.
WHO (2008). World Health Organization. Cervical cancer, human papillomavirus (HPV) and HPV vaccines: Key points for policy-makers and health professionals. WHO Press, 2008. World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland.
Bancroft, J. D.; Stevens, A.  (1990). Theory and practice of histopathological techniques. 2nd ed. Churchill and Livingistone: London.
Cohen, M. C., Wentzensen, N.; Castle, P. E.; Schiffman, M.; Zuna, R.; rend, R.; Clarke, M. A. (2023). Racial and ethnic disparities in cervical cancer incidence, survival and mortality by histologic subtypes. Journal 0f Clinical Oncology, 41(5): 1059-1068.
Elhasan LM, Bansal D, Osman OF, Enan K, Abd Farag EA. Prevalence of human papillomavirus type 16 in Sudanese women diagnosed with cervical carcinoma. Journal of cancer research and therapeutics. 2019 Oct 1;15(6):1316.
Hassan FM, KhirElseed M. Cervical cancer screening among Sudanese women. The Gulf journal of oncology. 2009 Jul 1(6):28-34.
Hause, Z.  H. (1996). Papillomavirus infections – a major cause of human cancers. Biochim Biophys Acta 1996, 1288(2):F55-78.
Husain NE, Burhan A, Ahmed IAI, Mohammed SI, Hammad N.  (2022). Women's cancers in Sudan with a focus on cervical cancer: turmoil, geopolitics and opportunities.  Ecancer 16 1433. doi: 10.3332/ecancer.
Husain, N.; Helali, T.; M Domi, M.; Bedri, S. (2011). Cervical cancer in women diagnosed at the National Health Laboratory, Sudan: A call for screening. Sudan JMS, 6(3): 183-189.
Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. Journal of the National cancer Institute. 2005 Jul 20;97(14):1072-9.
Khan S, Jaffer NN, Khan MN, Rai MA, Shafiq M, Ali A, Pervez S, Khan N, Aziz A, Ali SH: Human papillomavirus subtype 16 is common in Pakistaniwomen with cervical carcinoma. Int J Infect Dis 2007, 11: 313-317. 10.1016/j.ijid.2006.06.007.
Michelle J. Khan, Philip E. Castle, Attila T. Lorincz, Sholom Wacholder, Mark Sherman, David R. Scott, Brenda B. Rush, Andrew G. Glass, Mark Schiffman, The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice, JNCI: Journal of the National Cancer Institute, Volume 97, Issue 14, 20 July 2005, Pages 1072–1079.
Moneira Mansour, A.; Salih, M. M.; Shomo, A. E; Amel Bakheit, O. Elhassan M. M. (2013). Screening for Cervical Cancer and Its Association with Human Papilloma Virus (HPV) among Sudanese Women. Egypt. Acad. J. Biolog. Sci., 5(1): 101-106.
Sachan PL, Singh M, Patel ML, Sachan R. A study on cervical cancer screening using pap smear test and clinical correlation. Asia-Pacific journal of oncology nursing. 2018 Jul;5(3):337.
Sørbye SW, Suhrke P, Revå BW, Berland J, Maurseth RJ, Al-Shibli K. Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway. BMC clinical pathology. 2017 Dec;17(1):1-6.
Spencer J. C.; Kim, J.J.; Feldman, S. J.; Kobrin, S. C.; Skinner, C. S.; Wang, L.; McCarthy, M.; Atlas, S. J.; Pruitt, S. L.; Silver, M. I.; Haas, J. S. (2023). Racial and ethnic disparities in cervical cancer screening from three U.S. healthcare settings. American Journal of Preventive Medicine, Doi: https//doi.org/10.1016/j.amepre.2023.04.016.
Takeuchi S. Biology and treatment of cervical adenocarcinoma. Chinese Journal of Cancer Research. 2016 Apr;28(2):254.
Waggoner SE. Cervical cancer. The Lancet. 2003 Jun 28;361(9376):2217-25.